Blog

  • Tulip Siddiq – 2015 Parliamentary Question to the Department of Health

    Tulip Siddiq – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Tulip Siddiq on 2015-12-03.

    To ask the Secretary of State for Health, whether a person applying for NHS Continuing Healthcare support who is judged to be terminally ill and thus entitled to a 48-hour needs assessment by their clinical commissioning group (CCG) is able to claim the costs of any treatment over the 48-hour limit if the CCG does not make an assessment in time.

    Alistair Burt

    The NHS Continuing Healthcare (NHS CHC) Fast Track Pathway Tool is used when the individual has a rapidly deteriorating condition and the condition may be entering a terminal phase. The National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care (November 2012 revised) sets out that on receipt of the Fast Track documentation, the clinical commissioning group (CCG) should arrange for the care package to be commissioned without delay.

    A person only becomes eligible for NHS CHC once a decision on eligibility has been made by a CCG, informed either by a completed Decision Support Tool or Fast Track Pathway Tool. Prior to that decision being made, any existing arrangements for the provision and funding of care should continue, unless there is an urgent need for adjustment.

  • Justin Madders – 2015 Parliamentary Question to the Department of Health

    Justin Madders – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Justin Madders on 2015-12-03.

    To ask the Secretary of State for Health, pursuant to the Answer of 21 October 2015 to Question 12819, if he will provide an update on plans to introduce independent medical examiners to the death certification process.

    Ben Gummer

    Following the Spending Review, further work on the reforms to death certification will be subject to confirmation of spending priorities through the normal business planning cycle. We will provide an update on the implementation plans and timetables as soon as we are able.

  • Justin Madders – 2015 Parliamentary Question to the Department of Health

    Justin Madders – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Justin Madders on 2015-12-03.

    To ask the Secretary of State for Health, pursuant to the Answer of 21 October 2015 to Question 12818, on health services: weather, what data will be (a) collected and (b) published by NHS England.

    Jane Ellison

    Public Health England publishes a ‘winter health watch’ webpage each week throughout the winter. This includes a summary of the findings of our routine surveillance suitable for a non-technical audience, as well as links through to specific surveillance bulletins including surveillance for all- cause mortality, seasonal influenza, and norovirus.

    Details of the data that will be collected and published by NHS England can be found here:

    http://www.england.nhs.uk/statistics/statistical-work-areas/winter-daily-sitreps/

  • Nick Thomas-Symonds – 2015 Parliamentary Question to the Department of Health

    Nick Thomas-Symonds – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nick Thomas-Symonds on 2015-12-03.

    To ask the Secretary of State for Health, what arrangements his Department plans to put in place for new patients who wish to access drugs included in the Risk Sharing Scheme for the supply of disease modifying treatments for multiple sclerosis, glatiramer acetate and beta interferon after funding for that scheme ceases.

    George Freeman

    Colleagues are in discussion with NHS England colleagues to plan for a smooth transition from the end of the Scheme in England, and with colleagues in the Devolved Administrations in respect of Multiple Sclerosis services in their countries.

  • Crispin Blunt – 2015 Parliamentary Question to the Department of Health

    Crispin Blunt – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Crispin Blunt on 2015-12-03.

    To ask the Secretary of State for Health, if he will raise the issue of withdrawal of marketing authorisations for veterinary use of colistin at the next EU Employment, Social Policy, Health and Consumer Affairs Council on 7 December 2015.

    Jane Ellison

    The withdrawal of marketing authorisations for veterinary use of colistin was not raised at the EU Employment, Social Policy, Health and Consumer Affairs Council on 7 December 2015.

    The Public Health Minister has regularly discussed antimicrobial resistance (AMR) with her international colleagues and attended a meeting on AMR hosted by the Netherlands in advance of their forthcoming Presidency where the Minister raised the importance of a ‘One Health’ approach to AMR including the need for the appropriate use of antibiotics in both humans and animals.

    The five year UK Antimicrobial Resistance Strategy, published in 2013 takes a ‘One Health’ approach.

    Minimising the unnecessary and inappropriate use of antibiotics reduces the selective pressure that favours the emergence and spread of resistant bacteria and is an essential component of strategies to safeguard antibiotics critical for treatment of serious human infections.

    PHE is working closely with Defra, Department of Health, the Animal and Plant Health Agency, Food Standards Agency and Veterinary Medicines Directorate to ensure the latest evidence on colistin resistance is considered.

    AMR is a global problem that needs concerted action at both a national and global level.

  • Crispin Blunt – 2015 Parliamentary Question to the Department of Health

    Crispin Blunt – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Crispin Blunt on 2015-12-03.

    To ask the Secretary of State for Health, what discussions he has had with health experts on the human health implications of the veterinary use of colistin for colistin resistance in slaughtered animals, food and humans; and if he will make a statement.

    Jane Ellison

    The Department of Health is working closely with Public Health England (PHE), the Department for Environment Food and Rural Affairs, the Animal and Plant Health Agency, Food Standards Agency (FSA) and Veterinary Medicines Directorate to ensure that the risk assessment to public health from colistin-resistant bacteria from slaughtered animals, food and humans considers all available evidence. While PHE and the FSA judge that the public health risk of colistin-resistant bacteria from slaughtered animals and the food chain is very low, the use of colistin for animals will be reviewed following recent reports of transferable colistin resistance in China and Europe.

    I regularly discuss the issue of antimicrobial resistance with the Chief Medical Officer.

  • Henry Smith – 2015 Parliamentary Question to the Department of Health

    Henry Smith – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Henry Smith on 2015-12-03.

    To ask the Secretary of State for Health, what steps his Department is taking to raise public awareness of multiple myeloma and the risks presented by late diagnosis of acute myeloid leukaemia.

    Jane Ellison

    Public Health England’s ‘Be Clear on Cancer’ campaigns do not currently include multiple myeloma.

    A number of factors are taken into account when deciding which campaigns to develop and run, with one of the main criteria being the scope to save lives through earlier diagnosis and whether the cancer has a clear early sign or symptom that the general public can act upon should it arise.

    We appreciate that this means that there are a number of cancers, besides Myeloid Leukaemia, that are not covered by ‘Be Clear on Cancer’ specifically. Given this, Public Health England is looking at developing an approach to raise awareness of generic symptoms that can indicate a wider number of cancers and the need to visit the doctor promptly with these symptoms. This work is currently in development, with the help of a number of experts, including clinicians and charities.

  • Justin Madders – 2015 Parliamentary Question to the Department of Health

    Justin Madders – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Justin Madders on 2015-12-03.

    To ask the Secretary of State for Health, pursuant to the oral statement of 30 November 2015, Official Report, column 33, what estimate he has made of the number of operations that were cancelled prior to the proposed industrial action on 1 December 2015 but could not be rebooked for 1 December 2015 once that proposed industrial action was postponed.

    Ben Gummer

    On 30 November, based on information provided by hospital trusts, NHS England estimated that around 3,000 procedures that were due to take place on 1 December 2015 were planned to be rescheduled. It has not collected information or estimated how many of these could not be rebooked for 1 December 2015 once the proposed industrial action was suspended. There has been no estimate of how many vital procedures that were cancelled were rescheduled within 24 hours. These are operational matters for hospital trusts.

  • Stephen Phillips – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    Stephen Phillips – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Stephen Phillips on 2015-12-03.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, whether the UK plans to be represented before the Permanent Court of Arbitration in Philippines v. China.

    Mr Hugo Swire

    The UK is not party to the case of Philippines v China before the Permanent Court of Arbitration (PCA) of the United Nations Convention on the Law of the Sea (UNCLOS) and is therefore not entitled to be formally represented before the PCA in this case.

  • Stephen Phillips – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    Stephen Phillips – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Stephen Phillips on 2015-12-03.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, whether the UK is entitled to be represented before the Permanent Court of Arbitration in Philippines v. China.

    Mr Hugo Swire

    The UK is not party to the case of Philippines v China before the Permanent Court of Arbitration (PCA) of the United Nations Convention on the Law of the Sea (UNCLOS) and is therefore not entitled to be formally represented before the PCA in this case.